Hims and Hers , to Offer Weight Loss Injections.<br />GLP-1 medications like Ozempic and Wegovy have become increasingly popular.<br />However, the market has faced some supply constraints recently because of that popularity.<br />On May 20, Hims & Hers Health announced that it will be providing access to compounded GLP-1 weight loss injections, CNBC reports. .<br />Company shares jumped over 30% <br />following the announcement.<br />Compounded versions of medications are created <br />by certain manufacturers who meet FDA requirements when there are medication shortages.<br />However, the products are not tested <br />for safety and efficacy by the FDA.<br />The new offering of compounded GLP-1 medications can be accessed by getting a prescription from a health care provider on the Hims & Hers site.<br />Branded GLP-1 injections will be made available <br />once the supply becomes more consistent.<br />The price for compounded injections will <br />start at $199 per month, CNBC reports. .<br />Prior to announcing its GLP-1 offerings, <br />Hims & Hers revealed in an earnings report...<br />... that it anticipates its weight loss <br />program to garner over $100 million <br />worth of revenue by December 2025.<br />Hims & Hers CEO Andrew Dudum said that he is "confident" that a steady supply of the compounded injections will be available for customers.<br />We have a certain degree of <br />exclusivity with that facility that <br />will guarantee our consumers <br />consistent volume and supply, Hims & Hers CEO Andrew Dudum, via statement
